Reports to: Vice Chairman & Managing DirectorHeads the Global Anti-Virals Vertical with a global annual sales revenue in excess of US$ 250 Million with a geographical coverage of more than 120 countries across Asia, Africa, CIS/Russia & LATAM including Institutional clients such as USAID, Global Fund and all major MOHs.• Drives the strategic vision for the division by chalking out strategic areas/ molecules for future growth and aligning all stakeholders including R&D, RAD, Supply Chain & Manufacturing for timely decisions as well as resource allocations for successfully carrying out projects on time to uphold market leadership.• Formulating and executing the operational plans for the division through a strong team of professionals in business development, regulatory affairs, supply chain & logistics.• Periodically review market dynamics through data analytics for maximizing market opportunities & quickly build capacity expansions for increasing market share.• Responsibility includes in-licensing molecules for development through partnerships with innovator companies and other global agencies• Responsible for the entire gamut of Business Operations from product development to regulatory approvals(USFDA, Country regulatory approvals across Emerging Markets, DCGI) to commercialization across territories through both private & public markets.• Instrumental in making Aurobindo as a very strong global player/market leader in Anti-Retrovirals market• Completely turned around a loss-making division in 2012 (when I was given the responsibility) into a successful, consistent, profitmaking business unit.• Quickly grasped the major drivers of this market and built Aurobindo’s capabilities in a variety of areas to make it to the top 2 in ARVs.

Business Unit Head - Anti-Virals Portfolio.• Increasing Business Turnover from $ 110 Mn to $ 200 Mn in Five years. Got promoted as VP in 2016 after a successful turnaround. • Quickly Identified business drivers/opportunities in the ARV segment and influenced the Top management in the decision making process to yield high business growth and profits.• Successfully formulated & executed South Africa strategy for Anti-Retrovirals business and bagged the three year tender in excess of US$ 120 Million.• Converted many large institutional accounts & International Competitive Tenders to make Aurobindo a preferred partner through successful bidding and negotiations with key stakeholders.o Key accounts include USG(United States Govt.), The Global Fund and many other Country MOHs. • Identified new products with huge performance potential and worked with R&D and RA teams to shorten lead times for USFDA approvals and commercialization thereby driving growth.• Managed successfully regulatory filing and approvals in many countries across Africa, Asia, Latin America and CIS.• Instrumental in working on several In-licensing & Out-licensing opportunities and successfully drove the negotiations and discussions resulting in agreement contracts which can lead to a Top line valuation of US$ 200 Mn in additional revenues in the next three years.• Leading a team of over 40 professionals across geographies to achieve business objectives• Geography includes India, Asia, CIS, Russia, Africa, Middle East and LATAM.

Responsible for the global business of Anti-retrovirals division since April 2012.

Heading the Africa Region for the branded generic formulations. Resolved many issues in the areas of product portfolio, distribution, pricing and identifying appropriate business models for the various countries. Developed a strong team of professionals in the region. Built a good base for branded generics in Africa for Aurobindo.Direct Reports: Two Deputy General Managers, Two Senior Managers, Four Country Managers, One Customer Support Executive, two Product Managers and a team of 25 MRs under the Country ManagersProducts: Antibiotics (SSPs & Cephalosporins including Critical Care products such as Cefepime/Piptaz), CVS, CNSGeography Handled: Africa, Sri Lanka, Nepal, Mongolia, Iraq, Jordan & IndonesiaACCOMPLISHMENTS• Re-oriented the business strategy for the “Emerging Markets Division” in the region. • Built this business from a base of just US$ 3 Million in a period of three years to US$ 10 Million.• Developed a strong team and good common portfolio of products across the region for brand promotion.• Has been instrumental in building a strong network of distribution cum promotion partners across the various countries in the region which has contributed to the success.• Managing the marketing function through a team of product managers for brand campaigns and scientific support for promoting the various brands of the company.• Joined as AGM and got promoted as GM in 2 years.

• Head of Training & Field HR function. Designed and implemented the recruitment systems, Performance Management Systems (KRAs), Rewards & recognition programs for the sales and marketing division.• Identifying, segmenting and preparing talent to facilitate succession planning through assessment centres.

• Championed the Field force effectiveness (Training & Development & performance management) function for the India organization for both the Neurotoxin & Eye Care business.

• Successfully launched Botox in 1998 in India.• Established Botox in Neurology, Orthopedics & Cosmetology segments in India.• Developed a customer base of Neurologists/ Orthos/ Rehabs/ Derms/ Plastic surgeons in major cities in the various segments.• Developed a team of Product specialists by providing adequate training on product & consultative selling skills. Developed a strong distribution channel.• Created consumer awareness and demand-pull of the product through the print & electronic media PR activities.• Got promoted as Marketing Manager for India & South East Asia.

Heading Sales & Business Development operations for South India region.

Asst. Manager Patient care in charge of Tamil Nadu for Point of Care Diagnostics.

Medical Rep.